Skip to main content

JDRF is undergoing a transformation.
We are becoming Breakthrough T1D in October.

breakthrought1d logo

Media centre

The JDRF Media team is here to help journalists and producers with information on type 1 diabetes research, with facts and figures about type 1 diabetes, position statements, information on the celebrities giving their backing to JDRF and with any other enquiries.
Content last reviewed and updated: 09.08.2023

Are you a journalist seeking information about type 1 diabetes and our mission to prevent, treat and cure the condition? We are able to provide members of the media with:

For all media enquiries please email pressoffice@jdrf.org.uk. This email is monitored between 09:00 and 17:30 Monday to Friday.

Please note: the above email address is for enquiries from the media/journalists only. Please email info@jdrf.org.uk with all other enquiries.

Latest news

Read more
A researcher sits in a lab beside screening samples and lab equipment for early detection of type 1 diabetes.
Research
24 June 2024

New guidance sets out how to support people with early-stage type 1 diabetes

New international guidance detailing how to monitor and support people with early-stage type 1 diabetes (T1D) has the potential to reduce the trauma associated with being diagnosed with T1D, enable people to access the latest treatments to delay the need for insulin therapy, and reduce long-term health complications.

Read more
James Norton sitting in an armchair holding a teddy that has a CGM on it's arm. There is a plush woolly mammoth next to him.
Living with type 1
10 June 2024

James Norton to read CBeebies bedtime story about type 1 diabetes

JDRF ambassador James Norton will read a CBeebies Bedtime Story this Diabetes Awareness Week to help young children understand type 1 and how it can be managed

Read more
A row of vials of clear liquid with black lids. A blue gloved hand is pinching the top of the closest vial as if to pick it up.
Research
13 May 2024

Novel insulin being developed to enable implantable insulin pumps

Medtronic Diabetes have announced they are funding the biopharmaceutical company Arecor Therapeutics to develop a novel, highly concentrated, thermostable insulin, which will be specialised for use in implantable insulin pumps.

Read more
Professor Colin Dayan at Cardiff University, working on immunotherapy for type 1 diabetes cure research
Research
18 April 2024

Professor Colin Dayan presented with the 2023 JDRF Rumbough Award 

The award recognises Professor Dayan’s remarkable accomplishments in type 1 diabetes research.

Read more
Two young children sat on the floor hugging each other.
Research
18 April 2024

Genetically unique siblings reveal new treatment target for type 1 diabetes

Two siblings who have unique changes in a key gene have given researchers new insights that could help lead to innovative new treatments in type 1 diabetes.

Read more
A female doctor works at a laptop on a table. She is wearing a shirt and glasses with a stethoscope around her neck.
Prevention research
17 April 2024

New international medical code launches for presymptomatic type 1 diabetes

JDRF-funded researchers from the University of Birmingham have joined forces with NHS England to develop a diagnostic code for use on electronic medical records of people in the earliest stages of type 1 diabetes, allowing them to receive better, more timely healthcare and access to emerging treatments.

Read more
Professor Richard Oram in the Research, Innovation, Learning and Development (RILD) building at the University of Exeter.
7 March 2024

New biochip launches that detects genetic risk of type 1 diabetes

A new test by Randox, developed with JDRF-funded researchers at the University of Exeter, is the first in the world to use genetics to quickly identify who is at high risk of developing type 1 diabetes.

Read more
A graphic of a DNA double helix with a piece being removed demonstrating genetic engineering.
Cure research
21 February 2024

Primate with type 1 diabetes becomes insulin-independent after receiving gene-edited cells without immunosuppression

A transplant of stem cells grown into pancreatic islets has allowed a primate with type 1 to make its own insulin again.